Cargando…
Prevalence and clinical significance of VHL mutations and 3p25 deletions in renal tumor subtypes
Purpose: To evaluate prevalence and clinical impact of VHL mutations and deletions (3p), a cohort of consecutive kidney tumors was analyzed by DNA sequencing and fluorescence in-situ hybridization (FISH). Patients and Methods: The study includes 1,805 patients with renal tumors who were surgically t...
Autores principales: | Büscheck, Franziska, Fraune, Christoph, Simon, Ronald, Kluth, Martina, Hube-Magg, Claudia, Möller-Koop, Christina, Sarper, Imren, Ketterer, Kathrin, Henke, Tjark, Eichelberg, Christian, Dahlem, Roland, Wilczak, Waldemar, Sauter, Guido, Fisch, Margit, Eichenauer, Till, Rink, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6980626/ https://www.ncbi.nlm.nih.gov/pubmed/32076485 http://dx.doi.org/10.18632/oncotarget.27428 |
Ejemplares similares
-
Y-chromosome loss is frequent in male renal tumors
por: Büscheck, Franziska, et al.
Publicado: (2021) -
A non-diploid DNA status is linked to poor prognosis in renal cell cancer
por: Büscheck, Franziska, et al.
Publicado: (2020) -
Chromosome 17p13 deletion is associated with an aggressive tumor phenotype in clear cell renal cell carcinoma
por: Eichenauer, Till, et al.
Publicado: (2020) -
High level of EZH2 expression is linked to high density of CD8-positive T-lymphocytes and an aggressive phenotype in renal cell carcinoma
por: Eichenauer, Till, et al.
Publicado: (2020) -
Tumor cell PD-L1 expression is a strong predictor of unfavorable prognosis in immune checkpoint therapy-naive clear cell renal cell cancer
por: Möller, Katharina, et al.
Publicado: (2021)